STOCK TITAN
  1. Home
  2. Sec-filings
  3. TWST
  4. [144] Twist Bioscience Corp SEC Filing

Twist Bioscience (NASDAQ: TWST) insider to sell 669 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Twist Bioscience Corp (TWST) reported a planned sale of its common stock under Rule 144 for the account of officer Robert F. Werner. A brokerage firm filed to sell 669 shares, related to restricted stock vesting on 08/20/2026, with some shares covering a tax obligation from the vested equity award.

Werner also reported prior sales of common stock in the last three months totaling 3,014 shares across four transactions dated 05/21/2026, 05/26/2026, 06/08/2026, and 08/03/2026.

Positive

  • None.

Negative

  • None.
Shares to be sold 669 shares of Common Stock Planned Rule 144 sale related to restricted stock vesting on 08/20/2026
Aggregate market value of planned sale $93,035.42 Value associated with 669 shares of Twist Bioscience common stock
Shares sold on 05/21/2026 688 shares for $36,640.54 Common stock sales by Robert F. Werner during past 3 months
Shares sold on 05/26/2026 800 shares for $49,987.20 Common stock sales by Robert F. Werner during past 3 months
Shares sold on 06/08/2026 1,359 shares for $94,045.74 Common stock sales by Robert F. Werner during past 3 months
Shares sold on 08/03/2026 167 shares for $14,248.64 Common stock sales by Robert F. Werner during past 3 months
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
restricted stock vesting financial
"Common | 08/20/2026 | Restricted Stock Vesting | Issuer"
Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.
attorney-in-fact regulatory
"as attorney-in-fact for Robert Werner ATTENTION"
An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.
equity award distribution financial
"resulting from the settlement of a vested equity award distribution."

FAQ

What does Twist Bioscience (TWST) disclose in this Form 144 filing?
The filing discloses that officer Robert F. Werner plans to sell 669 shares of Twist Bioscience common stock under Rule 144, relating to restricted stock that vested on 08/20/2026, with part of the sale covering a tax obligation from the vested award.

How many TWST shares are planned for sale under this Form 144?
The notice covers a proposed sale of 669 shares of Twist Bioscience common stock. These shares are tied to the vesting of restricted stock on 08/20/2026 and include an amount to cover a related tax obligation from the equity award settlement.

What is the stated market value of the TWST shares in the planned sale?
The Form 144 lists an aggregate market value of $93,035.42 for the 669 shares of Twist Bioscience common stock proposed to be sold, based on the information provided in the securities information section.

What prior TWST stock sales by Robert F. Werner are disclosed?
The filing lists four prior sales of Twist Bioscience common stock in the past three months: 688 shares for $36,640.54, 800 shares for $49,987.20, 1,359 shares for $94,045.74, and 167 shares for $14,248.64, all attributed to Robert F. Werner.

Why does the Form 144 say some TWST shares are being sold?
The remarks state that the sale includes an amount necessary to cover a tax obligation arising from the settlement of a vested equity award distribution, indicating part of the shares sold will satisfy taxes linked to the restricted stock vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR